Status: Not yet recruiting
MRIdian "RADAR" Trial
The main purpose of this study is to see if treating cancer with the magnetic resonance imaging guided adaptive radiotherapy (MRIdian) can control patient's tumor and eliminate the need for surgery used to treat nerves in the spine flattened by pressure (compressed).
Participants needed: 24
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of MiamiUpdated: Apr 1, 2026Locations: 1
Eligibility criteria
Male and female participants ages ≥ 18. [+18]
Unknown primary histology [+8]